Portland, OR -- (SBWIRE) -- 10/13/2017 -- Progressive Markets has recently published a report on the healthcare sector, titled, "Global Point of Care Diagnostic Market- Size, Trend, Share, Opportunity Analysis, and Forecast 2014-2025". As per it, the global point of care diagnostic industry would increase at a CAGR of 9.4% during the period, 2017–2025. The research offers comprehensive analysis of factors that drive or impede growth of the industry. This aids stakeholder to recognize top investment pockets.

The study assesses global point of care diagnostic market share of product types, prescription modes, end-users, and regions for the period, 2014–2025. Further, the report evaluates industry size of each product type, prescription mode, and end-user by region for the historic period as well as forecast period, 2014–2016 and 2017–2025, respectively. It also explores factors that drive progress of the market, such as increase in investment by government.

The study offers introduction of the global point of care diagnostic market in terms of scope. It includes Porter's Five Forces Analysis (PFFA) to provide insightful information of competition in the industry. It analyzes certain parameters, such as power to bargain by suppliers & buyers and threat by substitutes & new entrepreneurs. In addition, the research incorporates summary of the industry. These include trend analysis, recent development, competitive landscape, and market attractiveness. It divides the industry into product types, prescription types, end-users, and geographies.

Get PDF Brochure of this Report: https://www.progressivemarkets.com/request-sample/point-of-care-diagnostic-market

The research assesses alternative aspects that fuel growth rate of the global point of care diagnostic market which includes rise in technology, demand for home based diagnostic method, and awareness. Moreover, it describes factors that hamper progress of the industry which include pricing pressure. It also describes top manufacturers of the market. These include Roche Diagnostics Limited, Siemens AG, Abbott Laboratories, Inc., Becton, Dickinson and Company, Alere Inc., Beckman Coulter, Inc., PTS Diagnostics, Johnson & Johnson, and Nova Biomedical.

The report splits prescription mode of the global point of care diagnostic market into over the counter (OTC) testing kits and prescription based testing kits. Regionally, it classifies the industry into Latin America Middle East & Africa (LAMEA), Asia-Pacific, Europe, and North America. Based on products, the study segments the market into glucose monitoring kits, infectious diseases testing kits, cardiometabolic monitoring kits, coagulation monitoring kits, tumor/cancer markers, pregnancy and fertility testing kits, urinalysis testing kits, hematology testing kits, cholesterol test strips, fecal occult testing kits, and drugs of abuse testing kits. According to it, the industry finds its end-users in professional diagnostic centers, home care, and research laboratories.

The report assesses above mentioned companies of the global point of care diagnostic market based on criterions set, such as recent advancements by each manufacturer. It also explores finance and business segment of every vendor. Apart from this, it also offers a brief introduction of every big market player. In addition, the research offers numerous significant takeaways of the industry, such as competitive intelligence within geographical locations of the market. It enables new entrants to have an in-depth understanding of consumer behavior as well as industry dynamics.

The research further categorizes products of the global point of care diagnostic market, such as cardiometabolic monitoring kits into cardiac markers, blood gas/electrolytes testing kits, lipids testing, and HbA1c Testing Kits. It also segments infectious diseases testing kits into influenza testing kits, hepatitis C testing kits, HIV testing kits, sexually-transmitted diseases (STDs) testing kits, healthcare-associated infections (HAIs)s, tropical diseases testing kits, and respiratory infections testing kits. The report bifurcates coagulation monitoring kits into activated clotting time (ACT/APTT) testing kits and prothrombin time (PT/INR) testing kits. It splits pregnancy and fertility testing kits into fertility testing kits and pregnancy testing kits.

Get Customized Report: https://www.progressivemarkets.com/request-customization/point-of-care-diagnostic-market